Amarin Announces Results of Annual General Meeting of Shareholders
April 22, 2024 08:00 ET
|
Amarin Corporation plc
DUBLIN, Ireland and BRIDGEWATER, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024...
Madison Realty Capital Hires Samir Tejpaul as Managing Director and Head of Capital Markets
April 22, 2024 08:00 ET
|
Madison Realty Capital
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Madison Realty Capital, a vertically integrated real estate private equity firm focused on real estate private credit, today announced that Samir Tejpaul...
STMicroelectronics Announces Status of Common Share Repurchase Program
April 22, 2024 08:00 ET
|
STMicroelectronics N.V.
STMicroelectronics Announces Status ofCommon Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 15, 2024 to Apr 19, 2024 AMSTERDAM – April 22, 2024 --...
Ilkka luopuu somessa.com Oy Ab:n liiketoiminnasta – Passiofy Oy ostaa vaikuttajamarkkinointitoimiston liiketoiminnan
April 22, 2024 08:00 ET
|
Ilkka Oyj
Ilkka Oyj Lehdistötiedote 22.4.2024, klo 15.00ILKKA LUOPUU SOMESSA.COM OY AB:N LIIKETOIMINNASTA – PASSIOFY OY OSTAA VAIKUTTAJAMARKKINOINTITOIMISTON LIIKETOIMINNANPassiofy Oy on ostanut...
ASML reports transactions under its current share buyback program
April 22, 2024 08:00 ET
|
ASML Netherlands BV
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share...
Gabelli Funds to Host 16th Annual Media & Entertainment Symposium Thursday, June 6, 2024
April 22, 2024 08:00 ET
|
Gabelli Funds
GREENWICH, Conn., April 22, 2024 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 16th Annual Media & Entertainment Symposium at the Harvard Club in New York City on Thursday, June 6, 2024. The...
Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024
April 22, 2024 08:00 ET
|
Sagimet Biosciences Inc.
SAN MATEO, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN)...
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
April 22, 2024 08:00 ET
|
Enlivex Therapeutics Ltd
Nes-Ziona, Israel, April 22, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that...
Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting
April 22, 2024 08:00 ET
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for...
TOKERO has successfully closed its Token Private funding round of $1.4 million
April 22, 2024 07:59 ET
|
TOKERO
TOKERO has successfully closed its Token Private funding round of $1.4 million.